SK Biopharm announced that its consolidated operating profit for the second quarter reached 97.064 billion won, a 56.9% increase compared to the same period last year.
During the same period, sales rose by 40.3% to 247.367 billion won. The net profit for the quarter was provisionally reported at 85.065 billion won, marking a significant increase of 188.1%.
* This article has been translated by AI.
Copyright ⓒ Aju Press All rights reserved.